Sansure Immunological Technology Platform adopts advanced nanoparticle technology, protein labelling and modification technology, using high quality coloured latex and colloidal gold as tracers, and has developed a series of easy-to-use, highly sensitive and rapid detection products, covering SARS-CoV-2 antigen, SARS-CoV-2/InFluA/InFluB antigen, SARS-CoV-2 neutralizing antibody and other SARS-CoV-2 immunological reagents, to meet the needs of different scenarios such as home self-test, POCT and laboratory testing.
It has been nearly three years since the outbreak of COVID-19 in 2020, during which time there have been several epidemic peaks triggered by mutated strains, especially the recent Omicron strain. Clinical data show that the Omicron strain is far more potent than influenza and other mutant strains of COVID-19, and that the strain can spread to about 9.5 people […]
Cervical cancer is the fourth largest malignant tumor harmful to women’s health, with a grim prevention and control situation. Although cervical cancer has a serious disease burden, it is relatively more preventable and controllable due to its relatively clear etiology. In 2020, the World Health Organization (WHO) officially issued the Global Strategy for the Accelerated Elimination of Cervical Cancer, specifying […]
According to statistics released by the WHO on April 23, recently, a total of 11 countries (especially the UK) have reported at least 169 cases of acute hepatitis of unknown cause in children. Along with the increase in the number of related cases, it is reported that one child has died of this disease. So far, the cause of this […]
I. Crucial virus strain in the new phase of the pandemic progression The Omicron strain has replaced the Delta strain as the predominant one circulating globally. Although several research teams and laboratories claim to have found recombinant viruses with mixed Delta and Omnicron variants in patients with Coronavirus, the transmissibility and pathogenicity of “Deltacron” is not yet clear, so mutations […]
Introduction to adenovirus Adenovirus (ADV) is a non-enveloped icosahedral virus with a double-stranded DNA genome. Since adenovirus was isolated from human tonsillar adenoids by Wallace P. Rowe in 1953 and named after it, more than 120 specific adenovirus serotypes have been identified in humans, mammals, birds, fish and reptiles. Adenovirus is divided into seven subgroups A, B, C, D, E, […]